Literature DB >> 33598870

Evaluation of multi-target deep neural network models for compound potency prediction under increasingly challenging test conditions.

Raquel Rodríguez-Pérez1,2, Jürgen Bajorath3.   

Abstract

Machine learning (ML) enables modeling of quantitative structure-activity relationships (QSAR) and compound potency predictions. Recently, multi-target QSAR models have been gaining increasing attention. Simultaneous compound potency predictions for multiple targets can be carried out using ensembles of independently derived target-based QSAR models or in a more integrated and advanced manner using multi-target deep neural networks (MT-DNNs). Herein, single-target and multi-target ML models were systematically compared on a large scale in compound potency value predictions for 270 human targets. By design, this large-magnitude evaluation has been a special feature of our study. To these ends, MT-DNN, single-target DNN (ST-DNN), support vector regression (SVR), and random forest regression (RFR) models were implemented. Different test systems were defined to benchmark these ML methods under conditions of varying complexity. Source compounds were divided into training and test sets in a compound- or analog series-based manner taking target information into account. Data partitioning approaches used for model training and evaluation were shown to influence the relative performance of ML methods, especially for the most challenging compound data sets. For example, the performance of MT-DNNs with per-target models yielded superior performance compared to single-target models. For a test compound or its analogs, the availability of potency measurements for multiple targets affected model performance, revealing the influence of ML synergies.

Entities:  

Keywords:  Deep neural networks; Machine learning; Model validation; Multi-target learning; Structure–activity relationships

Mesh:

Year:  2021        PMID: 33598870      PMCID: PMC7982389          DOI: 10.1007/s10822-021-00376-8

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  21 in total

1.  QSAR modeling: where have you been? Where are you going to?

Authors:  Artem Cherkasov; Eugene N Muratov; Denis Fourches; Alexandre Varnek; Igor I Baskin; Mark Cronin; John Dearden; Paola Gramatica; Yvonne C Martin; Roberto Todeschini; Viviana Consonni; Victor E Kuz'min; Richard Cramer; Romualdo Benigni; Chihae Yang; James Rathman; Lothar Terfloth; Johann Gasteiger; Ann Richard; Alexander Tropsha
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

2.  Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets.

Authors:  Jameed Hussain; Ceara Rea
Journal:  J Chem Inf Model       Date:  2010-03-22       Impact factor: 4.956

Review 3.  Deep learning in drug discovery: opportunities, challenges and future prospects.

Authors:  Antonio Lavecchia
Journal:  Drug Discov Today       Date:  2019-08-01       Impact factor: 7.851

4.  Computational Method for the Systematic Identification of Analog Series and Key Compounds Representing Series and Their Biological Activity Profiles.

Authors:  Dagmar Stumpfe; Dilyana Dimova; Jürgen Bajorath
Journal:  J Med Chem       Date:  2016-08-08       Impact factor: 7.446

Review 5.  A renaissance of neural networks in drug discovery.

Authors:  Igor I Baskin; David Winkler; Igor V Tetko
Journal:  Expert Opin Drug Discov       Date:  2016-07-04       Impact factor: 6.098

Review 6.  Machine learning in chemoinformatics and drug discovery.

Authors:  Yu-Chen Lo; Stefano E Rensi; Wen Torng; Russ B Altman
Journal:  Drug Discov Today       Date:  2018-05-08       Impact factor: 7.851

7.  ChEMBL: a large-scale bioactivity database for drug discovery.

Authors:  Anna Gaulton; Louisa J Bellis; A Patricia Bento; Jon Chambers; Mark Davies; Anne Hersey; Yvonne Light; Shaun McGlinchey; David Michalovich; Bissan Al-Lazikani; John P Overington
Journal:  Nucleic Acids Res       Date:  2011-09-23       Impact factor: 16.971

8.  Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set.

Authors:  Eelke B Lenselink; Niels Ten Dijke; Brandon Bongers; George Papadatos; Herman W T van Vlijmen; Wojtek Kowalczyk; Adriaan P IJzerman; Gerard J P van Westen
Journal:  J Cheminform       Date:  2017-08-14       Impact factor: 5.514

9.  Support Vector Machine Classification and Regression Prioritize Different Structural Features for Binary Compound Activity and Potency Value Prediction.

Authors:  Raquel Rodríguez-Pérez; Martin Vogt; Jürgen Bajorath
Journal:  ACS Omega       Date:  2017-10-04

10.  Prediction of Compound Profiling Matrices Using Machine Learning.

Authors:  Raquel Rodríguez-Pérez; Tomoyuki Miyao; Swarit Jasial; Martin Vogt; Jürgen Bajorath
Journal:  ACS Omega       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.